M’hammed Ansar

2.7k total citations · 2 hit papers
66 papers, 2.2k citations indexed

About

M’hammed Ansar is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Inorganic Chemistry. According to data from OpenAlex, M’hammed Ansar has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Organic Chemistry, 17 papers in Computational Theory and Mathematics and 14 papers in Inorganic Chemistry. Recurrent topics in M’hammed Ansar's work include Synthesis and biological activity (54 papers), Synthesis and Characterization of Heterocyclic Compounds (19 papers) and Computational Drug Discovery Methods (17 papers). M’hammed Ansar is often cited by papers focused on Synthesis and biological activity (54 papers), Synthesis and Characterization of Heterocyclic Compounds (19 papers) and Computational Drug Discovery Methods (17 papers). M’hammed Ansar collaborates with scholars based in Morocco, Saudi Arabia and United States. M’hammed Ansar's co-authors include Khalid Karrouchi, Smaail Radi, Youssef Ramli, Jamal Taoufik, Yahia N. Mabkhot, Faiz A. Al‐aizari, My El Abbés Faouzi, Silvia Antonia Brandán, Latifa Doudach and Yahia Cherrah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

M’hammed Ansar

59 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review

2018 759 citations Khalid Karrouchi, Smaail Radi et al. profile →
Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line

2019 247 citations Latifa Doudach, Youssef Ramli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M’hammed Ansar Morocco	19	1.8k	333	309	251	249	66	2.2k
Jamal Taoufik Morocco	15	1.2k 0.7×	217 0.7×	172 0.6×	132 0.5×	123 0.5×	59	1.5k
Youssef Ramli Morocco	24	2.0k 1.2×	310 0.9×	236 0.8×	181 0.7×	137 0.6×	202	3.1k
Ümmühan Özdemir Özmen Türkiye	24	841 0.5×	393 1.2×	150 0.5×	461 1.8×	142 0.6×	55	1.4k
Abdullah Mohammed Al‐Majid Saudi Arabia	27	1.9k 1.1×	471 1.4×	170 0.6×	276 1.1×	106 0.4×	154	2.4k
Senem Akkoç Türkiye	24	1.2k 0.7×	313 0.9×	183 0.6×	269 1.1×	55 0.2×	133	1.5k
Hassan M. Faidallah Saudi Arabia	22	1.3k 0.8×	463 1.4×	81 0.3×	72 0.3×	73 0.3×	119	1.6k
Lalitha Gummidi South Africa	18	1.6k 0.9×	407 1.2×	88 0.3×	70 0.3×	36 0.1×	47	2.0k
Samir Y. Abbas Egypt	26	1.8k 1.0×	546 1.6×	144 0.5×	425 1.7×	71 0.3×	79	2.2k
İrfan Koca Türkiye	16	782 0.4×	250 0.8×	164 0.5×	129 0.5×	211 0.8×	51	1.1k
Aliasghar Jarrahpour Iran	27	2.0k 1.1×	396 1.2×	90 0.3×	334 1.3×	104 0.4×	114	2.3k

Countries citing papers authored by M’hammed Ansar

Since Specialization

Citations

This map shows the geographic impact of M’hammed Ansar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M’hammed Ansar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M’hammed Ansar more than expected).

Fields of papers citing papers by M’hammed Ansar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M’hammed Ansar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M’hammed Ansar. The network helps show where M’hammed Ansar may publish in the future.

Co-authorship network of co-authors of M’hammed Ansar

This figure shows the co-authorship network connecting the top 25 collaborators of M’hammed Ansar. A scholar is included among the top collaborators of M’hammed Ansar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M’hammed Ansar. M’hammed Ansar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ansar, M’hammed, et al.. (2026). (E)-N'-(4-chlorobenzylidene)-5-methyl-1H-pyrazole-3-carbohydrazide as a potential PI3Kα targeting scaffold, synthesis, X-ray crystallography, DFT, molecular docking, molecular dynamics simulations, and MMGBSA analysis. Journal of Molecular Structure. 1359. 145569–145569.

Mortada, Salma, Walid Guerrab, Joel T. Mague, et al.. (2025). Novel hybrid pyridazinone-arylacetamide: Synthesis, crystal structure, toxicity, antidiabetic activity, oral starch tolerance test (OSTT), absorption distribution metabolism excretion toxicity (ADMET) and docking studies. Journal of Molecular Structure. 1352. 144480–144480.

Lai, Chin‐Hung, Salma Mortada, Arulraj Ramalingam, et al.. (2025). (E)-N'-(4-methoxybenzylidene)-2-((5-phenyl-1H-pyrazol-3-yl)oxy)acetohydrazide as potential antidiabetic agent: Synthesis, X-ray, Hirshfeld surface, biological evaluation and computational studies. Journal of Molecular Structure. 1349. 143934–143934. 1 indexed citations

Karrouchi, Khalid, et al.. (2025). Advancements in antiviral activity of aza-heterocyclic compounds: a review. Molecular Diversity. 1 indexed citations

Ramalingam, Arulraj, Salma Mortada, Utkirjon Holikulov, et al.. (2025). Synthesis, X-ray, Hirshfeld surface, DFT, non-covalent interaction, antihyperglycemic activity and molecular docking studies of (E)-N'-(2-chlorobenzylidene)-2-((5-phenyl-1H-pyrazol-3-yl)oxy)acetohydrazide. Journal of Molecular Structure. 1346. 143110–143110. 2 indexed citations

Mortada, Salma, Khalid Karrouchi, M. A. Bhat, et al.. (2024). Synthesis, structural characterizations, in vitro biological evaluation and computational investigations of pyrazole derivatives as potential antidiabetic and antioxidant agents. Scientific Reports. 14(1). 1312–1312. 47 indexed citations

Mortada, Salma, et al.. (2024). Design, synthesis, stereochemical characterization, in vitro α-glucosidase, and α-amylase inhibition and in silico studies of novel pyrazole-hydrazide hydrazones. Medicinal Chemistry Research. 34(1). 252–271. 7 indexed citations

Brandán, Silvia Antonia, et al.. (2024). 5-methyl-N'-(thiophen-2-ylmethylene)-1H-pyrazole-3-carbohydrazide as potent anticancer agent: Synthesis, spectroscopic characterization, anticancer activity and DFT studies. Journal of Molecular Structure. 1324. 140919–140919. 7 indexed citations

Guerrab, Walid, et al.. (2024). Synthesis, crystal structure and Hirshfeld surface analysis of 2-{4-[(2-chlorophenyl)methyl]-3-methyl-6-oxopyridazin-1-yl}-N-phenylacetamide. Acta Crystallographica Section E Crystallographic Communications. 80(11). 1221–1225.

10.

Brandán, Silvia Antonia, Salma Mortada, Abdullah Yahya Abdullah Alzahrani, et al.. (2024). Pyridazine derivative as potent antihyperglycemic agent: Synthesis, crystal structure, α-amylase and α-glucosidase inhibition and computational studies. Journal of Molecular Structure. 1308. 138145–138145. 9 indexed citations

11.

Brandán, Silvia Antonia, Salma Mortada, Suhana Arshad, et al.. (2023). 2-(allylthio)-5-(5-phenyl-1H-pyrazol-3-yl)-1,3,4-oxadiazole: Synthesis, single crystal XRD, spectroscopic characterization, antidiabetic activity, DFT and ADMET studies. Journal of Molecular Structure. 1295. 136620–136620. 21 indexed citations

12.

Karrouchi, Khalid, et al.. (2023). Recent Advances in the Synthesis of Pyrazole Derivatives: A Review. SHILAP Revista de lepidopterología. 4(3). 478–504. 73 indexed citations

13.

Mague, Joel T., et al.. (2023). 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide. SHILAP Revista de lepidopterología. 8(10). x230901–x230901.

14.

Doudach, Latifa, et al.. (2023). 2D-QSAR study and design of novel pyrazole derivatives as an anticancer lead compound against A-549, MCF-7, HeLa, HepG-2, PaCa-2, DLD-1. Computational Toxicology. 26. 100265–100265. 6 indexed citations

15.

Taoufik, Jamal, et al.. (2023). Synthesis, molecular structure, spectral characterization, and biological activities of ethyl 2-(4-(4-chlorobenzyl)-3-methyl-6-oxopyridazin-1(6H)-yl)acetate. Journal of Molecular Structure. 1289. 135867–135867. 4 indexed citations

16.

Mague, Joel T., et al.. (2022). Crystal structure and Hirshfeld surface analysis of (E)-3-benzylidene-4-oxopentanoic acid. Acta Crystallographica Section E Crystallographic Communications. 78(6). 563–567. 2 indexed citations

17.

Mague, Joel T., et al.. (2022). Ethyl 2-[4-(4-methoxybenzyl)-3-methyl-6-oxopyridazin-1-yl]acetate. SHILAP Revista de lepidopterología. 7(6). x220582–x220582. 3 indexed citations

18.

Samshuddin, S., et al.. (2020). 4-[(E)-3-(4-Methylphenyl)-3-oxoprop-1-en-1-yl]benzonitrile. SHILAP Revista de lepidopterología. 5(6). x200800–x200800.

19.

Ramli, Youssef, Jamal Taoufik, Joel T. Mague, et al.. (2019). Ethyl 2-(4-benzyl-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl)acetate: crystal structure and Hirshfeld surface analysis. Acta Crystallographica Section E Crystallographic Communications. 75(3). 392–396. 4 indexed citations

20.

Karrouchi, Khalid, M’hammed Ansar, Smaail Radi, Mohamed Saadi, & Lahcen El Ammari. (2015). Crystal structure ofN′-diphenylmethylidene-5-methyl-1H-pyrazole-3-carbohydrazide. SHILAP Revista de lepidopterología. 71(11). o890–o891. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact